Precigen, Inc. (PGEN) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Caribou Biosciences, Inc.

Agenus, Inc.

Precigen, Inc.

Scholar Rock Holding Corp.

Mineralys Therapeutics, Inc.

Edgewise Therapeutics, Inc.

iTeos Therapeutics, Inc.

Aldeyra Therapeutics, Inc.

Aerovate Therapeutics, Inc.

Lyell Immunopharma, Inc.

Nautilus Biotechnology, Inc.

Why is Precigen, Inc. ?

With a Operating Losses, the company has a Weak Long Term Fundamental Strength

Poor long term growth as Net Sales has grown by an annual rate of -46.64% over the last 5 years
Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -40.83

Negative results in Jun 25

ROCE(HY) Lowest at -668.03%
DEBT-EQUITY RATIO (HY) Highest at 926.05 %
OPERATING PROFIT(Q) Lowest at USD -27.23 MM

Risky - Negative EBITDA

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of 294.54%, its profits have risen by 2.6%

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Precigen, Inc. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Precigen, Inc.

334.13%

1.06

109.52%

S&P 500

13.22%

0.61

20.17%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-46.64%

EBIT Growth (5y)

5.71%

EBIT to Interest (avg)

-40.83

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-5.13

Sales to Capital Employed (avg)

0.00

Tax Ratio

1.14%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

30.61%

ROCE (avg)

ROE (avg)

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

29.24

EV to EBIT

-4.01

EV to EBITDA

-4.17

EV to Capital Employed

-5.84

EV to Sales

88.71

PEG Ratio

Dividend Yield

ROCE (Latest)

Negative Capital Employed

ROE (Latest)

-542.41%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Bullish

RSI

No Signal

Bollinger Bands

Mildly Bullish

Moving Averages

Mildly Bullish (Daily)

KST

Mildly Bearish

Bullish

Dow Theory

Mildly Bearish

OBV

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

8What is working for the Company

OPERATING CASH FLOW(Y)

Highest at USD -66.27 MM

NET PROFIT(HY)

Higher at USD -48.87 MM

RAW MATERIAL COST(Y)

Fallen by -68.84% (YoY

DEBTORS TURNOVER RATIO(HY)

Highest at 5.47 times

-8What is not working for the Company

ROCE(HY)

Lowest at -668.03%

DEBT-EQUITY RATIO (HY)

Highest at 926.05 %

OPERATING PROFIT(Q)

Lowest at USD -27.23 MM

PRE-TAX PROFIT(Q)

Lowest at USD -27.19 MM

NET PROFIT(Q)

Lowest at USD -27.2 MM

Here's what is working for Precigen, Inc.

Operating Cash Flow

Highest at USD -66.27 MM and Grown

In each year in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (USD MM)

Debtors Turnover Ratio

Highest at 5.47 times

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Raw Material Cost

Fallen by -68.84% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Precigen, Inc.

Operating Profit

Lowest at USD -27.23 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is negative

Operating Profit (USD MM)

Pre-Tax Profit

Lowest at USD -27.19 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (USD MM)

Pre-Tax Profit

At USD -27.19 MM has Fallen at -27.05%

over average net sales of the previous four periods of USD -21.4 MM

MOJO Watch

Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (USD MM)

Net Profit

Lowest at USD -27.2 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is negative

Net Profit (USD MM)

Net Profit

At USD -27.2 MM has Fallen at -29.74%

over average net sales of the previous four periods of USD -20.96 MM

MOJO Watch

Near term Net Profit trend is negative

Net Profit (USD MM)

Debt-Equity Ratio

Highest at 926.05 %

in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio